Original language | English (US) |
---|---|
Pages (from-to) | 727-742 |
Number of pages | 16 |
Journal | Clinics in Chest Medicine |
Volume | 43 |
Issue number | 4 |
DOIs | |
State | Published - Dec 2022 |
Bibliographical note
Funding Information:S.J. Schwarzenberg is a consultant for Abbvie, Mirium, Nestle, and UpToDate and has grant funding from the Cystic Fibrosis Foundation , the National Institutes of Health , and Gilead . T. Schindler is on the speaker board for Chiesi and Abbvie. The remaining authors have nothing to disclose.
Funding Information:
S.J. Schwarzenberg is a consultant for Abbvie, Mirium, Nestle, and UpToDate and has grant funding from the Cystic Fibrosis Foundation, the National Institutes of Health, and Gilead. T. Schindler is on the speaker board for Chiesi and Abbvie. The remaining authors have nothing to disclose.
Keywords
- Body composition
- Cardiovascular risk
- Cystic fibrosis transmembrane conductance regulator (CFTR)
- Highly effective modulator therapy
- Nutrient dense
PubMed: MeSH publication types
- Journal Article
- Review